Table 2 Clinicopathological characteristics of the patients
Items | PMLP | PCa with LN (−) | PCa with LN (+) |
|---|---|---|---|
No. of cases | 10 | 10 | 10 |
Median age (y, range) | 69 (57–82) | 67 (46–79) | 68 (52–83) |
Mean PSA (ng/ml, range) | 2.8 (0.54–4.82) | 12.63 (8.86–38.46) | 16.86 (10.07–87.22) |
Mean LDH (U/l, range) | 320.4 (153–560) | – | – |
Biopsy Gleason sum n | |||
≤ 6 | – | 3 | 1 |
3 + 4 | – | 3 | 3 |
4 + 3 | – | 2 | 3 |
8–10 | – | 2 | 3 |
Pathological Gleason sum n | |||
≤ 6 | – | 2 | 0 |
3 + 4 | – | 2 | 2 |
4 + 3 | – | 3 | 4 |
8–10 | – | 3 | 4 |
Pathological T stage n | |||
T2a | 0 | 2 | 0 |
T2b | 4 | 2 | 0 |
T2c | 5 | 5 | 0 |
≥ T3a | 1 | 1 | 10 |
Lymph node invasion n | |||
Negative | 10 | 10 | 0 |
Positive | 0 | 0 | 10 |